Phase II study of combination chemotherapy with cisplatin / pemetrexed / bevacizumab in patients with relapsed nonsquamous non-small cell lung cancer
Phase 2
- Conditions
- Relapsed nonsquamous non-small cell lung cancer
- Registration Number
- JPRN-UMIN000014291
- Lead Sponsor
- St. Marianna University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
nervous system metastasis haemoptysis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression free survival
- Secondary Outcome Measures
Name Time Method Response rate, Disease control rate, Overall survival, Toxicity, Disease failure interval